A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment

NCT05145270 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DIETARY_SUPPLEMENT: Escitalopram+Sulforaphane
DEVICE: Escitalopram+rTMS
DRUG: Escitalopram

Sponsor

Shanghai Mental Health Center